Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products.听
The global Transdermal & Transmucosal Drug Delivery System market is projected to grow from US$ 26570 million in 2024 to US$ 32660 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
A significant driver in the transdermal and transmucosal drug delivery system market is the demand for convenient and non-invasive drug administration methods. These systems offer painless and patient-friendly alternatives to traditional oral or injectable routes, improving medication adherence and patient comfort. However, a notable challenge in this market is the formulation complexity and variability in patient responses. Developing effective drug delivery systems that consistently deliver precise dosages and account for individual variations in skin or mucosal permeability presents a challenge. Manufacturers must focus on optimizing formulations and ensuring predictable drug release to maximize the potential of transdermal and transmucosal drug delivery systems in providing efficient and patient-centered healthcare solutions.
Report Covers:
This report presents an overview of global market for Transdermal & Transmucosal Drug Delivery System, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Transdermal & Transmucosal Drug Delivery System, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Transdermal & Transmucosal Drug Delivery System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transdermal & Transmucosal Drug Delivery System sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Transdermal & Transmucosal Drug Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Transdermal & Transmucosal Drug Delivery System sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Viatris
Teva
Zosano Pharma
Segment by Type
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Segment by Application
Hospitals
Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Transdermal & Transmucosal Drug Delivery System in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Transdermal & Transmucosal Drug Delivery System manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal & Transmucosal Drug Delivery System sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Transdermal & Transmucosal Drug Delivery System Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal & Transmucosal Drug Delivery System Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Transdermal Drug Delivery System
1.2.3 Transmucosal Drug Delivery System
1.3 Market by Application
1.3.1 Global Transdermal & Transmucosal Drug Delivery System Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transdermal & Transmucosal Drug Delivery System Sales Estimates and Forecasts 2019-2030
2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Region
2.2.1 Global Transdermal & Transmucosal Drug Delivery System Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Region (2019-2024)
2.2.3 Global Transdermal & Transmucosal Drug Delivery System Revenue by Region (2025-2030)
2.2.4 Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share by Region (2019-2030)
2.3 Global Transdermal & Transmucosal Drug Delivery System Sales Estimates and Forecasts 2019-2030
2.4 Global Transdermal & Transmucosal Drug Delivery System Sales by Region
2.4.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Transdermal & Transmucosal Drug Delivery System Sales by Region (2019-2024)
2.4.3 Global Transdermal & Transmucosal Drug Delivery System Sales by Region (2025-2030)
2.4.4 Global Transdermal & Transmucosal Drug Delivery System Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Manufacturers
3.1.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Manufacturers (2019-2024)
3.1.2 Global Transdermal & Transmucosal Drug Delivery System Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Transdermal & Transmucosal Drug Delivery System in 2023
3.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Manufacturers
3.2.1 Global Transdermal & Transmucosal Drug Delivery System Revenue by Manufacturers (2019-2024)
3.2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Transdermal & Transmucosal Drug Delivery System Revenue in 2023
3.3 Global Key Players of Transdermal & Transmucosal Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Transdermal & Transmucosal Drug Delivery System Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Transdermal & Transmucosal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Transdermal & Transmucosal Drug Delivery System, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Transdermal & Transmucosal Drug Delivery System, Product Offered and Application
3.8 Global Key Manufacturers of Transdermal & Transmucosal Drug Delivery System, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Type
4.1.1 Global Transdermal & Transmucosal Drug Delivery System Historical Sales by Type (2019-2024)
4.1.2 Global Transdermal & Transmucosal Drug Delivery System Forecasted Sales by Type (2025-2030)
4.1.3 Global Transdermal & Transmucosal Drug Delivery System Sales Market Share by Type (2019-2030)
4.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Type
4.2.1 Global Transdermal & Transmucosal Drug Delivery System Historical Revenue by Type (2019-2024)
4.2.2 Global Transdermal & Transmucosal Drug Delivery System Forecasted Revenue by Type (2025-2030)
4.2.3 Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share by Type (2019-2030)
4.3 Global Transdermal & Transmucosal Drug Delivery System Price by Type
4.3.1 Global Transdermal & Transmucosal Drug Delivery System Price by Type (2019-2024)
4.3.2 Global Transdermal & Transmucosal Drug Delivery System Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Application
5.1.1 Global Transdermal & Transmucosal Drug Delivery System Historical Sales by Application (2019-2024)
5.1.2 Global Transdermal & Transmucosal Drug Delivery System Forecasted Sales by Application (2025-2030)
5.1.3 Global Transdermal & Transmucosal Drug Delivery System Sales Market Share by Application (2019-2030)
5.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Application
5.2.1 Global Transdermal & Transmucosal Drug Delivery System Historical Revenue by Application (2019-2024)
5.2.2 Global Transdermal & Transmucosal Drug Delivery System Forecasted Revenue by Application (2025-2030)
5.2.3 Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share by Application (2019-2030)
5.3 Global Transdermal & Transmucosal Drug Delivery System Price by Application
5.3.1 Global Transdermal & Transmucosal Drug Delivery System Price by Application (2019-2024)
5.3.2 Global Transdermal & Transmucosal Drug Delivery System Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Transdermal & Transmucosal Drug Delivery System Market Size by Type
6.1.1 US & Canada Transdermal & Transmucosal Drug Delivery System Sales by Type (2019-2030)
6.1.2 US & Canada Transdermal & Transmucosal Drug Delivery System Revenue by Type (2019-2030)
6.2 US & Canada Transdermal & Transmucosal Drug Delivery System Market Size by Application
6.2.1 US & Canada Transdermal & Transmucosal Drug Delivery System Sales by Application (2019-2030)
6.2.2 US & Canada Transdermal & Transmucosal Drug Delivery System Revenue by Application (2019-2030)
6.3 US & Canada Transdermal & Transmucosal Drug Delivery System Market Size by Country
6.3.1 US & Canada Transdermal & Transmucosal Drug Delivery System Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Transdermal & Transmucosal Drug Delivery System Sales by Country (2019-2030)
6.3.3 US & Canada Transdermal & Transmucosal Drug Delivery System Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Transdermal & Transmucosal Drug Delivery System Market Size by Type
7.1.1 Europe Transdermal & Transmucosal Drug Delivery System Sales by Type (2019-2030)
7.1.2 Europe Transdermal & Transmucosal Drug Delivery System Revenue by Type (2019-2030)
7.2 Europe Transdermal & Transmucosal Drug Delivery System Market Size by Application
7.2.1 Europe Transdermal & Transmucosal Drug Delivery System Sales by Application (2019-2030)
7.2.2 Europe Transdermal & Transmucosal Drug Delivery System Revenue by Application (2019-2030)
7.3 Europe Transdermal & Transmucosal Drug Delivery System Market Size by Country
7.3.1 Europe Transdermal & Transmucosal Drug Delivery System Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Transdermal & Transmucosal Drug Delivery System Sales by Country (2019-2030)
7.3.3 Europe Transdermal & Transmucosal Drug Delivery System Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Transdermal & Transmucosal Drug Delivery System Market Size
8.1.1 China Transdermal & Transmucosal Drug Delivery System Sales (2019-2030)
8.1.2 China Transdermal & Transmucosal Drug Delivery System Revenue (2019-2030)
8.2 China Transdermal & Transmucosal Drug Delivery System Market Size by Application
8.2.1 China Transdermal & Transmucosal Drug Delivery System Sales by Application (2019-2030)
8.2.2 China Transdermal & Transmucosal Drug Delivery System Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Transdermal & Transmucosal Drug Delivery System Market Size by Type
9.1.1 Asia Transdermal & Transmucosal Drug Delivery System Sales by Type (2019-2030)
9.1.2 Asia Transdermal & Transmucosal Drug Delivery System Revenue by Type (2019-2030)
9.2 Asia Transdermal & Transmucosal Drug Delivery System Market Size by Application
9.2.1 Asia Transdermal & Transmucosal Drug Delivery System Sales by Application (2019-2030)
9.2.2 Asia Transdermal & Transmucosal Drug Delivery System Revenue by Application (2019-2030)
9.3 Asia Transdermal & Transmucosal Drug Delivery System Sales by Region
9.3.1 Asia Transdermal & Transmucosal Drug Delivery System Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Transdermal & Transmucosal Drug Delivery System Revenue by Region (2019-2030)
9.3.3 Asia Transdermal & Transmucosal Drug Delivery System Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Transdermal & Transmucosal Drug Delivery System Market Size by Type
10.1.1 Middle East, Africa and Latin America Transdermal & Transmucosal Drug Delivery System Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Transdermal & Transmucosal Drug Delivery System Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Transdermal & Transmucosal Drug Delivery System Market Size by Application
10.2.1 Middle East, Africa and Latin America Transdermal & Transmucosal Drug Delivery System Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Transdermal & Transmucosal Drug Delivery System Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Transdermal & Transmucosal Drug Delivery System Sales by Country
10.3.1 Middle East, Africa and Latin America Transdermal & Transmucosal Drug Delivery System Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Transdermal & Transmucosal Drug Delivery System Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Transdermal & Transmucosal Drug Delivery System Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 3M
11.1.1 3M Company Information
11.1.2 3M Overview
11.1.3 3M Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 3M Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 3M Recent Developments
11.2 Antares Pharma
11.2.1 Antares Pharma Company Information
11.2.2 Antares Pharma Overview
11.2.3 Antares Pharma Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Antares Pharma Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Antares Pharma Recent Developments
11.3 Aveva Drug Delivery Systems
11.3.1 Aveva Drug Delivery Systems Company Information
11.3.2 Aveva Drug Delivery Systems Overview
11.3.3 Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Aveva Drug Delivery Systems Recent Developments
11.4 Corium International
11.4.1 Corium International Company Information
11.4.2 Corium International Overview
11.4.3 Corium International Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Corium International Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Corium International Recent Developments
11.5 DURECT
11.5.1 DURECT Company Information
11.5.2 DURECT Overview
11.5.3 DURECT Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 DURECT Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 DURECT Recent Developments
11.6 Pantec Biosolutions
11.6.1 Pantec Biosolutions Company Information
11.6.2 Pantec Biosolutions Overview
11.6.3 Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pantec Biosolutions Recent Developments
11.7 Tapemark
11.7.1 Tapemark Company Information
11.7.2 Tapemark Overview
11.7.3 Tapemark Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Tapemark Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Tapemark Recent Developments
11.8 Tesa Labtec
11.8.1 Tesa Labtec Company Information
11.8.2 Tesa Labtec Overview
11.8.3 Tesa Labtec Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Tesa Labtec Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tesa Labtec Recent Developments
11.9 Viatris
11.9.1 Viatris Company Information
11.9.2 Viatris Overview
11.9.3 Viatris Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Viatris Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Viatris Recent Developments
11.10 Teva
11.10.1 Teva Company Information
11.10.2 Teva Overview
11.10.3 Teva Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Teva Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Recent Developments
11.11 Zosano Pharma
11.11.1 Zosano Pharma Company Information
11.11.2 Zosano Pharma Overview
11.11.3 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Zosano Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Transdermal & Transmucosal Drug Delivery System Industry Chain Analysis
12.2 Transdermal & Transmucosal Drug Delivery System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transdermal & Transmucosal Drug Delivery System Production Mode & Process
12.4 Transdermal & Transmucosal Drug Delivery System Sales and Marketing
12.4.1 Transdermal & Transmucosal Drug Delivery System Sales Channels
12.4.2 Transdermal & Transmucosal Drug Delivery System Distributors
12.5 Transdermal & Transmucosal Drug Delivery System Customers
13 Market Dynamics
13.1 Transdermal & Transmucosal Drug Delivery System Industry Trends
13.2 Transdermal & Transmucosal Drug Delivery System Market Drivers
13.3 Transdermal & Transmucosal Drug Delivery System Market Challenges
13.4 Transdermal & Transmucosal Drug Delivery System Market Restraints
14 Key Findings in The Global Transdermal & Transmucosal Drug Delivery System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Viatris
Teva
Zosano Pharma
听
听
*If Applicable.
